Projects per year
Personal profile
Biography
Associate Professor Alberta Hoi is a rheumatologist, leading lupus expert and translational researcher in Australia. Her research focusses on disease predictors and outcomes, registry design and implementation, quality of care and patient-centred interactions.
She has received her undergraduate medical degree from Melbourne University (1996), and completed a doctoral of philosophy in immunology on a NHMRC scholarship from Monash University. She is a fellow of the Royal Australasian College of Physician and member of the Australian Rheumatology Association (ARA). Her current clinical activities include seeing patients at Monash Lupus Clinic, where she serves as the Clinic Head, as well as Complex Rheumatology Clinic at Monash Health, and Autoimmune Clinic at Austin Health.
She is a chief investigator and senior research fellow at the Centre for Inflammatory Diseases, School of Clinical Sciences Monash University. She has developed core set measurements and studied factors that determine optimal outcomes in SLE, and she was pivotal in the successful roll out of the Australian Lupus Registry & Biobank, a national disease registry that serves as a valuable research resource, that foster collaboration between translational scientists and clinicians at national and international levels.
Associate Professor Alberta Hoi plays an active role in a number of investigator-initiated SLE studies and clinical trials. Currently she is the chair and custodian of the Australian Lupus Registry & Biobank Steering committee. She is also on the executive committee and a founding member of the Asia-Pacific Lupus Collaboration (APLC). She serves on an honorary basis as the treasurer for the Victorian branch ARA and the Australian Chinese Medical Association Victoria.
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects
A Phase 1b/2 Study of KZR-616 in Patients Rheumatic Disease with Active Inflammatory Arthritis and in Patients with Lupus Nephritis
1/11/19 → 31/10/24
Project: Research
Research Output
Factors associated with damage accrual in patients with systemic lupus erythematosus with no clinical or serological disease activity: a multicentre cohort study
Apostolopoulos, D., Kandane-Rathnayake, R., Louthrenoo, W., Luo, S. F., Jan Wu, Y. J., Lateef, A., Golder, V., Sockalingam, S., Navarra, S. T. V., Zamora, L., Hamijoyo, L., Katsumata, Y., Harigai, M., Chan, M., O'Neill, S., Goldblatt, F., Lau, C. S., Li, Z. G., Hoi, A., Nikpour, M. & 2 others, , Jan 2020, In : The Lancet Rheumatology. 2, 1, p. e24-e30 7 p.Research output: Contribution to journal › Article › Research › peer-review
1
Citation
(Scopus)
Analysis of serum B cell-activating factor from the tumor necrosis factor family (BAFF) and its soluble receptors in systemic lupus erythematosus
Vincent, F. B., Kandane-Rathnayake, R., Koelmeyer, R., Hoi, A., Harris, J., Mackay-Fisson, F. & Morand, E. F., 1 Jan 2019, In : Clinical & Translational Immunology. 8, 4, 11 p., e1047.Research output: Contribution to journal › Article › Research › peer-review
Open Access
File
2
Citations
(Scopus)
A potential association between IL-3 and type I and III interferons in systemic lupus erythematosus
Oon, S., Monaghan, K., Ng, M., Hoi, A., Morand, E., Vairo, G., Maraskovsky, E., Nash, A. D., Wicks, I. P. & Wilson, N. J., 24 Dec 2019, In : Clinical & Translational Immunology. 8, 12, 8 p., e01097.Research output: Contribution to journal › Article › Research › peer-review
Open Access
File
Attainment of the lupus low disease activity state is associated with protection from damage accrual in patients with active disease at baseline
Golder, V., Morand, E. F., Kandane-Rathnayake, R., Huq, M., Nim, H., Louthrenoo, W., Luo, S. F., Wu, Y-J., Lateef, A., Sockalingam, S., Navarra, S. T. V., Zamora, L., Hamijoyo, L., Katsumata, Y., Harigai, M., Chan, M., O’Neill, S., Goldblatt, F., Sing Lau, C., Li, Z. & 2 others, , 2019, p. 203-203. 1 p.Research output: Contribution to conference › Abstract
Comparison of effects of DORIS remission and lupus low disease activity state (LLDAS) on disease outcomes in a multinational prospective study
Morand, E., Golder, V., Kandane-Rathnayake, R., Huq, M., Nim, H., Louthrenoo, W., Luo, S. F., Lateef, A., Sockalingam, S., Navarra, S., Hamijoyo, L., Katsumata, Y., Chan, M., Hoi, A. & Nikpour, M., 2019. 1 p.Research output: Contribution to conference › Abstract